Mohr PJ - Search Results

1

Single-agent inhibition of Chk1 is antiproliferative in human cancer cell lines in vitro and inhibits tumor xenograft growth in vivo.

Davies KD, Humphries MJ, Sullivan FX, von Carlowitz I, Le Huerou Y, Mohr PJ, Wang B, Blake JF, Lyon MA, Gunawardana I, Chicarelli M, Wallace E, Gross S. Davies KD, et al. Among authors: mohr pj. Oncol Res. 2011;19(7):349-63. doi: 10.3727/096504011x13079697132961. Oncol Res. 2011. PMID: 21936404

2

C5-Alkyl-2-methylurea-Substituted Pyridines as a New Class of Glucokinase Activators.

Du X, Hinklin RJ, Xiong Y, Dransfield P, Park J, Kohn TJ, Pattaropong V, Lai S, Fu Z, Jiao X, Chow D, Jin L, Davda J, Veniant MM, Anderson DA, Baer BR, Bencsik JR, Boyd SA, Chicarelli MJ, Mohr PJ, Wang B, Condroski KR, DeWolf WE, Conn M, Tran T, Yang J, Aicher TD, Medina JC, Coward P, Houze JB. Du X, et al. Among authors: mohr pj. ACS Med Chem Lett. 2014 Nov 22;5(12):1284-9. doi: 10.1021/ml500341w. eCollection 2014 Dec 11. ACS Med Chem Lett. 2014. PMID: 25516785 Free PMC article.

3

Discovery of Disubstituted Imidazo[4,5-b]pyridines and Purines as Potent TrkA Inhibitors.

Wang T, Lamb ML, Block MH, Davies AM, Han Y, Hoffmann E, Ioannidis S, Josey JA, Liu ZY, Lyne PD, MacIntyre T, Mohr PJ, Omer CA, Sjögren T, Thress K, Wang B, Wang H, Yu D, Zhang HJ. Wang T, et al. Among authors: mohr pj. ACS Med Chem Lett. 2012 Jul 26;3(9):705-9. doi: 10.1021/ml300074j. eCollection 2012 Sep 13. ACS Med Chem Lett. 2012. PMID: 24900538 Free PMC article.

4

Identification of 4-aminopyrazolylpyrimidines as potent inhibitors of Trk kinases.

Wang T, Lamb ML, Scott DA, Wang H, Block MH, Lyne PD, Lee JW, Davies AM, Zhang HJ, Zhu Y, Gu F, Han Y, Wang B, Mohr PJ, Kaus RJ, Josey JA, Hoffmann E, Thress K, Macintyre T, Wang H, Omer CA, Yu D. Wang T, et al. Among authors: mohr pj. J Med Chem. 2008 Aug 14;51(15):4672-84. doi: 10.1021/jm800343j. Epub 2008 Jul 23. J Med Chem. 2008. PMID: 18646745

5

Convergent enantioselective synthesis of the tricyclic core of phomactin A.

Mohr PJ, Halcomb RL. Mohr PJ, et al. Org Lett. 2002 Jul 11;4(14):2413-6. doi: 10.1021/ol026159t. Org Lett. 2002. PMID: 12098260

6

Total synthesis of (+)-phomactin a using a B-alkyl Suzuki macrocyclization.

Mohr PJ, Halcomb RL. Mohr PJ, et al. J Am Chem Soc. 2003 Feb 19;125(7):1712-3. doi: 10.1021/ja0296531. J Am Chem Soc. 2003. PMID: 12580592

7

Synthesis of the reported structure of pogostol and a total aynthesis of (+/-)-kessane without the use of protecting groups.

Booker-Milburn KI, Jenkins H, Charmant JP, Mohr P. Booker-Milburn KI, et al. Org Lett. 2003 Sep 4;5(18):3309-12. doi: 10.1021/ol035373u. Org Lett. 2003. PMID: 12943414

8

CODATA Recommended Values of the Fundamental Physical Constants: 2018.

Tiesinga E, Mohr PJ, Newell DB, Taylor BN. Tiesinga E, et al. Among authors: mohr pj. J Phys Chem Ref Data. 2021 Sep;50(3):033105. doi: 10.1063/5.0064853. Epub 2021 Sep 23. J Phys Chem Ref Data. 2021. PMID: 36726646 Free PMC article.

9

CODATA recommended values of the fundamental physical constants: 2018.

Tiesinga E, Mohr PJ, Newell DB, Taylor BN. Tiesinga E, et al. Among authors: mohr pj. Rev Mod Phys. 2021 Apr-Jun;93(2):025010. doi: 10.1103/RevModPhys.93.025010. Epub 2021 Jun 30. Rev Mod Phys. 2021. PMID: 36733295 Free PMC article.

10

Clinical outcomes of endovascular treatment of TASC-II C and D femoropopliteal lesions with the Viabahn endoprosthesis.

Mohr PJ, Oyama JK, Luu JT, Stinis CT. Mohr PJ, et al. Cardiovasc Revasc Med. 2015 Dec;16(8):465-8. doi: 10.1016/j.carrev.2015.09.001. Epub 2015 Sep 10. Cardiovasc Revasc Med. 2015. PMID: 26483319

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters